Mr Simon Agius
Consultant to the Natural Products Wellness Sector
Simon Agius, has had a diverse 12 year career in the Natural health, Anti aging & Biochemistry sector and is currently the CEO of This is Natural.com, a Natural Products Marketplace that is currently in it is BETA 2 release version Since 1998, Simon Agius has been a participant in the Natural Products and Wellness Sector in a variety of positions.
Between 2004 and 2007, Simon worked alongside Dr. Bill Elliot Cham and Curaderm Global Ltd, the Biochemical manufacturer of Curaderm-BEC5. Simon has also been engaged with a variety of companies in the Natural products, Cosmetic and Nutraceutical ingredients sector of the United States, Japan, United Kingdom and his childhood home of Vanuatu. Simon has had several articles published on the subject of Tamanu oil, which he was one of the marketing pioneers. Tamanu is currently one of the fastest growing natural oil products gaining popularity in the United States and beyond. Simon Agius is currently employed as a Educator, Marketer, Market research, Botanical research and Consultant to the Natural Products industry as the CEO of ThisisNatural.com.
Curaderm-BEC5 in 2010, the Past, Present and Future of a Clinically Proven, Non Melanoma Skin Cancer & Keratosis Cream Treatment
This paper explores, from a consumers/clinical observers perspective, a review of the most important areas of scientific and medical evidence that demonstrates the clinically proven success of Curaderm-BEC5 for the treatment of malignant and non malignant, non-melanoma & keratosis skin cancer cream. Curaderm-BEC5 is a 98% natural cream formulation first published by Dr. Bill Elliot Cham in 1980 and made commercially available, under patent, since 1990.
The paper begins with a summary of the “marketing hype” of Curaderm-BEC5 as presented on internet websites world wide. There are several consistent themes of benefits made available by the manufacturer and mentioned within tens of thousands of websites. Therefore, a standard list of clinically relevant user information, in layman’s terms, will be presented.
The how question is then immediately explored. Specifically, the unique and ground breaking discovery that glycoalkaloids solasodine glycosides (BEC) causes the death of cancer cells without affecting normal cells. The presenter will show the unique mode of action discovered by Biochemist Dr. Bill Elliot Cham and his team of researchers at the University of Queensland and subsequently independently verified by a myriad of scientists and biochemists world wide. A secondary aspect of the how will also be explored, specifically, how does one use Curaderm-BEC5. The steps of a usual Curaderm treatment will be explained within the perspective of the unique Mode of Action. Clinical examples and published research will be shown for cases of Keratosis. Basal cell carcinoma and Squamous cell carcinoma.
Since it is politically correct to question any potential cure for cancer, the presenter will briefly summarise some other ongoing cancer research, directly related to the BEC discovery independent of Dr. Cham. Regarding specifically the success of Curaderm-BEC5 in 2010, the presenter will summarise some independent clinical reviews by respected Medical Professionals. The specific references will demonstrate why the word cancer can be used correctly when associated with the acronym of research collectively termed “BEC''.
Finally, a few recent case studies & anecdotal testimonial by users will be presented. The paper concludes with a very recent revelation that should have Medical Professionals turning their head towards learning more about this breakthrough cream technology that was first formulated in 1980.
View .pdf of Presentation here!